IMAGINE AN INDIA where everyone can access advanced and affordable healthcare, pop the latest pills made by Indian laboratories at Indian prices, and get their blood work or brain scans from diagnostics facilities that do not gouge them.
Wait! Don’t go away! We can work towards that vision over the next five years, given the rapid advances in healthcare, pharma and communications technologies and how the sector attracts foreign investment.
Today, Indian healthcare exists in two landscapes. In urban India, gleaming hospitals sprout every other day, and reputable government hospitals such as AIIMS New Delhi serve over 7,000 outpatients daily. The pharmaceutical industry has gained a name worldwide (and many companies have manufacturing facilities across the globe). Almost all the latest diagnostic tests are available in this India.
In the other landscape, basic healthcare is a dream: Primary health centres remain unmanned, snakebite victims give up the ghost under the local quack, and district government hospitals refer routine cases to medical colleges, which are supposed to be for tertiary care.
Can India improve healthcare? What should the new government I due in June this year prescribe?
ROAD MAP TO A HEALTHIER FUTURE
Rural India is not in the pink of health. The government says the doctor-patient ratio is 1:847, which means one doctor for every 847 people. This looks better than the World Health Organization’s recommended ratio of 1:1000, but the Indian ratio factors in 565,000 AYUSH doctors apart from the 1.3 million or so allopathic doctors.
Indians also report an alarming 60% out-of-pocket expenditure on healthcare, one of the highest globally, going by the World Bank’s numbers. A surge in chronic diseases adds to the stress on the healthcare system.
This story is from the February 18, 2024 edition of Business Today India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 18, 2024 edition of Business Today India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
The Dark Side Of Gold Loans
There Has Been A Sharp Rise In Gold Loans In Recent Years. But There Is A Seedier Side To This, As Is Evident From The Red Flag The RBI Raised Recently. Will The Regulator's Move Protect Customers?
All That Glitters
The price of gold has been rising unabated. It has soared to more than 73,000 per 10 gm in 2024 from *31,000 in early 2018. Is the rally sustainable or is this a bubble?
"Hire for attitude, not ability"
Thryve Digital is a player in the healthcare technology sector delivering next-generation solutions
Road Warrior
For Khalid Wani, Senior Director of Sales at Western Digital India, life is much more than just the corner office. Biking across the world is one way he derives meaning for his life
WIDENING THE POOL
THERE HAS BEEN A JUMP IN INDIVIDUALS INVESTING DIRECTLY IN THE STOCK MARKETS, BUT MUMBAI AND AHMEDABAD STILL ACCOUNT FOR THE LION'S SHARE. THERE DEFINITELY IS SCOPE FOR IMPROVEMENT IN TERMS OF PENETRATION LEVELS ACROSS THE COUNTRY
CRISIS IN THE CLOUDS
INDIAN AVIATION IS IN CRISIS. AIRLINES ARE GRAPPLING WITH FLIGHT CANCELLATIONS, CREW SHORTAGES, AND COMPLAINTS ABOUT POOR SERVICE, ARE BLEEDING DUE TO RISING COSTS WILL THE FASTEST-GROWING AVIATION MARKET RECOVER?
"India should start privatising public sector banks"
Arvind Panagariya, Chairman of the 16th Finance Commission, on growth, inequality, jobs, the banking sector, and more
"I LET MY WORK DO THE TALKING"
Megha Engineering & Infrastructures MD P.V. Krishna Reddy on being low profile, the infra opportunity and much more
"Core of insurance lies in long-term security"
Vibha Padalkar, MD & CEO of HDFC Life, on the insurance provider's performance, surrender charges, and future innovations
Distress in the Books
Bandhan Bank, the brainchild of Chandra Shekhar Ghosh, has made the journey from an MFI to a bank, but with many hurdles. Now with his resignation as MD & CEO, is the lender staring at more uncertainty?
